TransMedics Group, Inc. (TMDX) Financials

TMDX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 706.0 million 568.8 million
2023-09-30 689.2 million 562.8 million
2023-06-30 690.4 million 545.1 million
2023-03-31 287.1 million 94.5 million

TMDX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -33.5 million 5.7 million
2023-09-30 -141.8 million 5.2 million
2023-06-30 -7.2 million 5.0 million
2023-03-31 -9.6 million 3.9 million

TMDX Net Income

No data available :(

TMDX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 9.7 million
2023-09-30 427.1 million - 10.2 million
2023-06-30 582.2 million - 10.3 million
2023-03-31 195.4 million 58.8 million 8.5 million

TMDX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 32.6 million
2023-09-30 32.6 million
2023-06-30 32.5 million
2023-03-31 32.3 million

TMDX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 41.8 million 10.8 million 34.6 million -
2023-09-30 134.9 million 38.3 million 30.7 million -
2023-06-30 1.4 million 8.3 million 27.9 million 1.4 million
2023-03-31 927000 5.9 million 25.0 million -

TMDX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 81.2 million 33.3 million
2023-09-30 66.4 million 25.8 million
2023-06-30 52.5 million 15.7 million
2023-03-31 41.6 million 12.8 million

TMDX

Price: $94.13

52 week price:
36.42
99.63

Earnings Per Share: -0.77 USD

P/E Ratio: -79.52

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Volume: 513900

Market Capitalization: 3.1 billion

Links: